Target intelligence / Profile preview

Vagal afferent signaling

Molecular classification
Other
01

Overview

Vagal afferent signaling refers to the collective transmission of sensory information from internal organs (notably the heart, gastrointestinal tract, lungs, pancreas, and liver) to the brain via the afferent fibers of the vagus nerve[1][2][3][5][9]. These sensory fibers outnumber motor (efferent) fibers in the vagus nerve by approximately 4:1 to 9:1, depending on the organ system, and play a central role in physiological homeostasis, including the regulation of heart rate, gastrointestinal motility and secretion, food intake, glucose metabolism, immune responses, and inflammatory signaling[1][3][4][6]. Sensory inputs are derived from diverse specialized endings (mechanosensors, chemosensors, stretch receptors) and utilize various neurotransmitters (e.g., glutamate) to relay information to brainstem nuclei, such as the nucleus tractus solitarius (NTS)[1][3][4]. The pathways exhibit functional plasticity in response to physiological status (e.g., feeding, obesity, inflammation) and are implicated in numerous diseases, but the term itself does not denote a discrete therapeutic target[2][4][5][10].

Other names
Vagal sensory signalingVagal sensory pathwayVagal afferent pathway
02

Mechanism of action

Mechanisms depend on individual receptors or channels within afferent fibers, e.g., GLP-1 receptor agonism, serotonin receptor modulation, glutamatergic signaling modulation.

03

Biological functions

Signal transductionHomeostatic regulationInteroceptionVisceral sensory integration
04

Disease associations

Cardiovascular diseaseObesityGastrointestinal disordersRespiratory diseaseNeurodegenerative diseaseInflammation
05

Safety considerations

Not a druggable target per sePerturbation of vagal afferent signaling can result in bradycardiaPerturbation of vagal afferent signaling can result in hypotensionPerturbation of vagal afferent signaling can result in anorexiaPerturbation of vagal afferent signaling can result in impaired homeostasis
06

Biomarkers

No single biomarkerMay depend on disease context, such as altered response to satiety hormonesHeart rate variability as a readout of vagal tone

Beyond the preview

Go deeper on Vagal afferent signaling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vagal afferent signaling.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call